You can pick a custom keyboard shortcut, and you can decide to simply press that shortcut instead of pressing and holding it.

ATLANTA — STEM Atlanta is adapting to recent changes in government funding, leading the organization to pivot its focus while continuing its mission to provide diverse scholars with resources in STEM ...

The North Carolina Tar Heels just finished a disappointing first year under head coach Bill Belichick, going 4-8 overall and 2-6 in ACC play. And now, they are making some staff moves. On Friday, the ...

BERLIN — Learning how to write takes time, whether it is holding your pen properly or ensuring all the letters are on the same straight line. These days, some children roll their eyes, wondering why ...

Just a few days ago Mississippi State head coach Jeff Lebby teased a potential change on the coaching staff after finishing the 2025 season with a 5-7 record. "We’re in the middle of evaluating every ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? My name is Cori Ritchey, and I am an exercise physiology nerd turned fitness ...

While out navigating the holiday rush you can also get a jump on spring cleaning under a new statewide paint recovery program. The Paint Stewardship Act, which went into effect Monday, lets residents ...

The coaching carousel in college football is starting to thin out. Currently, Penn State remains open, and with each passing day, it’s becoming clear that firing James Franklin was a mistake with no ...

What if building advanced AI-powered search systems didn’t require a team of engineers or months of development? Imagine uploading a few files, tweaking minimal settings, and instantly allowing your ...

The Commonwealth of Pennsylvania made a historic $2 million investment in the Food Bucks program, a nutrition incentive initiative aimed at expanding access to fresh fruits and vegetables for SNAP ...

Regeneron is adding its name to Tessera Therapeutics’ unique in vivo gene-writing program, inking a deal that lets it in on a prospect for alpha-1 antitrypsin deficiency (AATD) through a $150 million ...